Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
ConditionAnaphylaxis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCharite University, Berlin, Germany
About this trial
The Anaphylaxis Registry aims to assess data in a standardized form about symptoms, triggers, cofactors and therapy management from patients who experienced an anaphylactic reaction. This should improve diagnosis and long-term management of these life-threatening allergic reactions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Anaphylactic reaction within the past 12 months
Disqualifiers
None
Trial population
Subjects who experienced a severe anaphylactic reaction and presenting in a participating center
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
not applicable, observational study
Other interventionPatients do not receive intervention; observational study
Treatment groups
20,000 Participants
are divided into 1 treatment groupGroup A: Anaphylactic reaction (observational)1 intervention
Trial outcomes
Primary outcomes
1
Influence of risk factors
Correlation between risk factors (age, epiphenomenon, comorbidity) and severity of anaphylaxis
Time frame
10 yearsSecondary outcomes
1
Epiphenomenon
Correlation between epiphenomenoa of the anaphylaxis and the frequency of allergic reactions
Time frame
10 years2
Current use of adrenaline
Assessment of acute treatments with adrenaline
Time frame
10 years3
Future use of adrenaline
Comparison of the frequencies of the use of adrenaline from beginning to end of the observation
Time frame
10 years4
Country-specific differences in anaphylaxis handling
Comparison of the triggers, diagnosis, treatment and prophylaxis of anaphylactic reactions throughout different countries
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov